Letter to the Editor: Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature
Letter to the Editor: Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature. Annals of Oncology. 2007; 18(1):197-198, author reply 198-9.